Genea Biocells Expands Operations Center In San Diego, California
06/25/2015
Genea Biocells' new premises include office and laboratory space to accommodate the company's cell and culture media manufacturing, research services and R&D. According to the firm, the move represents a substantial investment in California with the new site housing over $2 million worth of equipment, including sophisticated robotics and instrumentation for screening.
The site is expected to be fully operational from September 2015 and by early 2016 will house up to 15 scientists. "This is an exciting strategic move and the next step to grow Genea Biocells into a world leading stem cell company. The new facility not only places us directly into our main market, the USA, but also in the midst of one of the largest biotechnology clusters in the world," Genea Biocells General Manager Dr. Uli Schmidt said.
"Being in California also offers a new range of funding opportunities that we will explore to support our R&D programs on neuromuscular diseases,” he added.
Project Announcements
Create Energy Expands-Plans Sumner County-Robertson County, Tennessee, Operations
03/20/2026
United Kingdom-Based Dechra Plans Boston, Massachusetts, Headquarters Operations
03/20/2026
France-Based Bel Group Expands Brookings, South Dakota, Production Operations
03/20/2026
Menco Plans Menominee County, Michigan, Operations
03/20/2026
Southern Energy Renewables Plans St. Charles Parish, Louisiana, Methanol-Aviation Fuel Operations
03/20/2026
FCH Plans West Chester, Ohio, Production Operations
03/20/2026
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
What Companies Need from Modern Manufacturing Sites
Q1 2026
-
Economic Developer Role Shifting from Deal-Making to Systems Stewardship
Q1 2026
-
Capitalizing on the OBBBA Before the 2026 Cliff
Q1 2026
-
The Skilled Trades Are Ready for a Digital Future
Q4 2025
-
Amazon’s First Mass Timber Delivery Station Tests the Future of Low-Carbon Logistics
Q4 2025
-
Last Word: Don’t Lose by Winning
Q1 2026